COMP <GO>
CVS vs PETS // EV/EBITDA & P/E VALUATION
CVS Health Corporation (NYSE) VS. PetMed Express Inc. (NASDAQ) • 15-METRIC TALLY: CVS 10
— PETS 0
■ METRIC PARITY
LAST: $90.33 (+0.42%) • MKT CAP: $115.53B
valuation
25.7x
LAST: $1.18 (-0.84%) • MKT CAP: $25.6M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVS VS. PETS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVS | PETS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.00% | 28.10% | +16.90 | CVS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.60% | -35.00% | +37.60 | CVS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 25.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.76% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 1.20% | -32.80% | +34.00 | CVS | /operating-margins <GO> |
| Net Profit Margin | 0.40% | -32.00% | +32.40 | CVS | /net-margins <GO> |
| Revenue Growth (YoY) | 7.80% | -21.10% | +28.90 | CVS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.94% | 0.08% | +2.86 | CVS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.31 | 0.24 | +2.07 | CVS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 2/9 | +5.00 | CVS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.8 | 34.1 | +13.69 | CVS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 60.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $115.53B | $25.6M | $115.50B | CVS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVS REV | PETS REV | CVS GROSS % | PETS GROSS % | CVS FCF | PETS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $402.07B | $179.0M | 45.0% | 28.1% | $7.81B | -$33.0M |
| FY 2024 | $372.81B | $227.0M | 44.7% | 30.5% | $6.33B | -$395.0K |
| FY 2023 | $357.78B | $274.1M | — | — | -$2.67B | $4.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVS // BETA 0.88
PETS // BETA —